Management
Participation in high-quality clinical trials is the preferred treatment at all points in breast cancer therapy 2.
Patient Reported Outcomes (PROs) assessment can aid in individualized patient profiling, involving caregivers, and providing comfort and support in oncology 1.Key Recommendations
Participation in high-quality clinical trials is the preferred treatment at all points in breast cancer therapy 2. (Evidence: Strong)
Patient Reported Outcomes (PROs) assessment is decisive in oncology, improving caregiver-patient-physician communication, identifying patient risk groups, detecting unmet problems and needs, tracking disease course and treatment, providing prognostic markers, measuring cost-effectiveness, and offering comfort/support for patients and caregivers 1. (Evidence: Strong)
Successful implementation of PROs assessment in daily clinical oncology practice requires institutional involvement, caregiver adherence, continuous team training and support, clear workflows, continuous monitoring, and data analysis 1. (Evidence: Strong)References
1 Silveira A, Sequeira T, Gonçalves J, Lopes Ferreira P. Patient reported outcomes in oncology: changing perspectives-a systematic review. Health and quality of life outcomes 2022. link
2 Carlson RW, Edge SB, Theriault RL. NCCN: Breast cancer. Cancer control : journal of the Moffitt Cancer Center 2001. link